03 December 2002 - U.S. Patent and Trademark Office

TM 212 OFFICIAL GAZETTE DEC 3, 2002
SN 76-404,352. OSPREY PHARMACUETICALS LTD., CAL-
GARY, ALBERTA, CANADA, FILED 5-7-2002.
OSPREY
PHARMACEUTICALS
NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO
USE "PHARMACEUTICALS", APART FROM THE MARK
AS SHOWN.
CLASS 1—CHEMICALS
FOR CHEMICAL AND BIOCHEMICAL PRODUCTS
AND BIOLOGICAL AGENTS, NAMELY, CELLS,
VIRUSES, GENES, BACTERIA, MONOCLONAL ANTI-
BODIES, AND PROTEINS, AND MUTATIONS AND
COMBINATIONS THEREOF FOR MEDICAL RE-
SEARCH, SCIENTIFIC RESEARCH, DIAGNOSTIC RE-
SEARCH AND THERAPEUTIC RESEARCH USE (U.S.
CLS. 1, 5, 6, 10, 26 AND 46).
CLASS 5—PHARMACEUTICALS
FOR CHEMICAL AND BIOCHEMICAL PRODUCTS
AND BIOLOGICAL AGENTS, NAMELY. CELLS,
VIRUSES, GENES, BACTERIA, MONOCLONAL ANTI-
BODIES, AND PROTEINS, AND MUTATIONS AND
COMBINATIONS THEREOF FOR CLINICAL OR MEDI-
CAL LABORATORY USE (U.S. CLS. 6, 18, 44, 46, 51 AND
52).
CLASS 42—SCIENTIFIC, COMPUTER AND
LEGAL SERVICES
FOR SCIENTIFIC AND MEDICAL RESEARCH,
NAMELY, INVESTIGATING, ANALYZING, VERIFYING
AND VALIDATING DIAGNOSTIC AND THERAPEUTIC
REAGENTS AND COMPOUNDS USED IN THE TREAT-
MENT OF LEUKOCYTE MEDICATED DISEASES; BIO-
MEDICAL LABORATORY SERVICES, NAMELY, THE
COLLECTION, PROCESSING, ANALYSIS, SCREENING,
TESTING, TYPING AND STORAGE OF HUMAN TIS-
SUE, BLOOD, BLOOD COMPONENTS AND STEM
CELLS; REFERENCE AND CLINICAL LABORATORY
SERVICES FOR OTHERS, NAMELY, THE TESTING,
SCREENING, AND ANALYSIS OF BIOLOGICAL SUB-
STANCES, HUMAN LEUKOCYTE ANTIGEN DNA AND
SEROLOGICAL TYPING AND BLOOD TYPING; BIOME-
DICAL PATHOLOGY AND LABORATORY MEDICINE
CONSULTATION SERVICES FOR OTHERS (U.S. CLS.
100 AND 101).
SN 76-404,353. OSPREY PHARMACUETICALS LTD., CAL-
GARY, ALBERTA, CANADA, FILED 5-7-2002.
CLASS 1—CHEMICALS
FOR CHEMICAL AND BIOCHEMICAL PRODUCTS
AND BIOLOGICAL AGENTS, NAMELY, CELLS,
VIRUSES, GENES, BACTERIA, MONOCLONAL ANTI-
BODIES, AND PROTEINS, AND MUTATIONS AND
COMBINATIONS THEREOF, FOR MEDICAL RE-
SEARCH, SCIENTIFIC RESEARCH, DIAGNOSTIC RE-
SEARCH AND THERAPEUTIC RESEARCH USE (U.S.
CLS. 1, 5, 6, 10, 26 AND 46).
CLASS 5—PHARMACEUTICALS
FOR CHEMICAL AND BIOCHEMICAL PRODUCTS
AND BIOLOGICAL AGENTS, NAMELY, CELLS,
VIRUSES, GENES, BACTERIA, MONOCLONAL ANTI-
BODIES, AND PROTEINS, AND MUTATIONS AND
COMBINATIONS THEREOF FOR CLINICAL OR MEDI-
CAL LABORATORY USE (U.S. CLS. 6, 18, 44, 46, 51 AND
52).
CLASS 42—SCIENTIFIC, COMPUTER AND
LEGAL SERVICES
FOR SCIENTIFIC AND MEDICAL RESEARCH,
NAMELY, INVESTING, ANALYZING, VERIFYING
AND VALIDATING DIAGNOSTIC AND THERAPEUTIC
REAGENTS AND COMPOUNDS USED THE TREAT-
MENT OF LEUKOCYTE MEDICATED DISEASES; BIO-
MEDICAL LABORATORY SERVICES, NAMELY, THE
COLLECTION, PROCESSING, ANALYSIS, SCREENING,
TESTING, TYPING AND STORAGE OF HUMAN TIS-
SUE, BLOOD, BLOOD COMPONENTS AND STEM
CELLS; REFERENCE AND CLINICAL LABORATORY
SERVICES FOR OTHERS, NAMELY, THE TESTING,
SCREENING, AND ANALYSIS OF BIOLOGICAL SUB-
STANCES, HUMAN LEUKOCYTE ANTIGEN DNA AND
SEROLOGICAL TYPING AND BLOOD TYPING; BIOME-
DICAL PATHOLOGY AND LABORATORY MEDICINE
CONSULTATION SERVICES FOR OTHERS (U.S. CLS.
100 AND 101).